Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In spite of major medical advances in heart transplant patients, psychiatric comorbidity remains very high in pre-and post-transplant phases. Anxiety and depression are especially frequent. They impact significantly morbidity and mortality. Especially because they are associated with poor therapeutic adherence and risks of infection and rejection. The inability to make beneficial therapeutic choice can be explained by the negative perception of events, associated with anxio-depressive disorders. This results in an important deterioration in quality of life of patients.
The investigators assume that better management of emotions might reduce the stress of waiting situation and its psychopathological and somatic consequences pre-and post-transplant.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| psychotherapeutic intervention | Experimental | The psychotherapeutic intervention "stress management" is based on therapeutic, behavioral and cognitive strategies. They are active and put the patient "actor" of his "adaptation" of the heart transplantation entire process. The approached components are emotional, cognitive and behavioral (techniques of communication and problem solving). |
|
| Usual medical care | No Intervention |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Stress management | Behavioral |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of the impact of a psychotherapeutic intervention on the quality of life of cardiac transplant patients. | The quality of life is assessed with the MLHFQ - Minnesota Living with Heart Failure Questionnaire. | The quality of life is evaluated before the cardiac transplantation and during the 12 months after the cardiac transplantation. |
| Measure | Description | Time Frame |
|---|---|---|
| Anxiety manifestations pre-and post-transplant | Anxiety manifestations pre-and post-transplant measured with the State-Trait Anxiety Inventory | Before the cardiac transplantation and during 12 months after the cardiac transplantation |
| Depressive symptoms pre-and post-transplant |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Mohamed SAOUD, Pr | Contact | mohamed.saoud@chu-lyon.fr |
| Name | Affiliation | Role |
|---|---|---|
| Mohamed SAOUD, Pr | Hospices Civils de Lyon | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Service de Psychiatrie d'Adultes Liaison/Consultation, | Recruiting | Bron | 69677 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
depressive symptoms pre-and post-transplant measured using the Beck Depression Inventory (BDI-II) |
| Before the cardiac transplantation and during 12 months after the cardiac transplantation |
| Pre and post-transplant major clinical events | Before the cardiac transplantation and during 12 months after the cardiac transplantation |
| Hospitalization modalities around the graft | by measuring the duration of stay in hospital, number of surgery necessary | Before the cardiac transplantation and during 12 months after the cardiac transplantation |
| Somatic complications after the heart transplantation | by measuring the mortality rate and number of graft rejection | During 12 months after the cardiac transplantation |
| The therapeutic adherence pre-and post-transplant | using an adherence questionnaire | Before the cardiac transplantation and during 12 months after the cardiac transplantation |
| Pôle de Psychiatrie et de Neurologie | Not yet recruiting | Grenoble | France |
|